HomeLarge Type Edition
HOME ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
PubMed
Right arrow PubMed Citation
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 56:M719-M723 (2001)
© 2001 The Gerontological Society of America

Age and Gender Effects on Cardiomyocyte Apoptosis in the Normal Human Heart

Ziad Mallata, Paul Fornesb, Rémi Costagliolab, Bruno Espositoa, Joël Belminc, Dominique Lecomteb and Alain Tedguia

a Institut National de la Santé et de la Recherche Médicale, Institut Fédératif de Recherche "Circulation Lariboisière," Paris
b Département de Médecine Légale, Faculté de Médecine Cochin-Port Royal, Université Paris V, and Institut Médico-Légal de Paris
c Service de Médecine Interne Gériatrique, Hôpital René Muret-Bigottini, and Université Paris XIII, Sevran, France

Joël Belmin, Service de Médecine Interne Gériatrique, Hôpital René Muret et Université Paris Nord, 93270 Sevran, France E-mail: joel.belmin{at}rmb.ap-hop-paris.fr.

Decision Editor: John E. Morley, MB, BCh

Background. Animal studies have suggested that apoptosis could play a significant role in the myocardial aging process. Although no information is available in humans, the paradigm that cardiomyocyte apoptosis is increased in the aged human heart has been widely propagated. Moreover, it is unknown whether gender differences may influence cardiomyocyte apoptosis.

Methods. Cardiomyocyte apoptosis was compared between subjects ranging in age from 21 to 93 years (22 men and 19 women), free of any cardiovascular disease, who died of either violent or natural causes. Strict inclusion and exclusion criteria were used to ensure that the selected hearts accurately represented normal aging.

Results. Apoptosis was detected using the TdT-mediated dUTP digoxigenin nick end labeling (TUNEL) technique (controls for TUNEL included negative staining for splicing factor SC-35 and for Ki-67 antigen). The percentage of cardiomyocyte death ranged from 0% to 0.0437%, with no correlation with the age of the subject (p = .85). However, the percentage of apoptosis was threefold higher in men than in women (0.0133% ± 0.0030% vs 0.0042% ± 0.0008%, respectively; p < .01).

Conclusions. Our results in humans do not support the hypothesis that aging influences the percentage of cardiomyocyte apoptosis. However, gender appears to be an important determinant of the occurrence of apoptosis.




This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
M. Steenman, Y.-W. Chen, M. Le Cunff, G. Lamirault, A. Varro, E. Hoffman, and J. J. Leger
Transcriptomal analysis of failing and nonfailing human hearts
Physiol Genomics, January 15, 2003; 12(2): 97 - 112.
[Abstract] [Full Text] [PDF]




HOME ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by The Gerontological Society of America.